122 related articles for article (PubMed ID: 8068150)
41. pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Li J; Shi L; Zhang X; Sun B; Yang Y; Ge N; Liu H; Yang X; Chen L; Qian H; Wu M; Yin Z
Oncotarget; 2016 Jan; 7(3):2646-59. PubMed ID: 26544731
[TBL] [Abstract][Full Text] [Related]
42. Hepatocellular carcinoma extension into the right atrium.
Hayashi P; Trotter JF; Everson GT
Liver Transpl; 2003 Nov; 9(11):1225-6. PubMed ID: 14586886
[No Abstract] [Full Text] [Related]
43. Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?
Hesketh RL; Zhu AX; Oklu R
Diagn Interv Radiol; 2015; 21(1):78-84. PubMed ID: 25430530
[TBL] [Abstract][Full Text] [Related]
44. Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line.
Urano Y; Watanabe K; Lin CC; Hino O; Tamaoki T
Cancer Res; 1991 Mar; 51(5):1460-4. PubMed ID: 1847664
[TBL] [Abstract][Full Text] [Related]
45. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
46. [Pulmonary tumor embolism in primary cancer of the liver].
Kolarski V; Dimitrova B; Chemishanski G
Vutr Boles; 1990; 29(2):84-8. PubMed ID: 2173285
[TBL] [Abstract][Full Text] [Related]
47. Research progress and prospects of circulating tumor cells in hepatocellular carcinoma.
Li CC; Yang HY; Mao YL
Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):514-515. PubMed ID: 35853804
[No Abstract] [Full Text] [Related]
48. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
49. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
[TBL] [Abstract][Full Text] [Related]
50. An unusual cause of acute pulmonary embolism.
Huang HK; Huang CH; Wu CC; Chen WJ
Int J Cardiol; 2011 Jun; 149(2):e88-e89. PubMed ID: 20591513
[No Abstract] [Full Text] [Related]
51. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
[TBL] [Abstract][Full Text] [Related]
52. [Report of an autopsy cases of hepatocellular carcinoma with marked pulmonary hypertension due to multiple pulmonary thrombus].
Ohta H; Matsumoto A; Mizukami Y; Nakano Y; Ohta T; Arisato S; Murakami M; Orii Y; Sato T
Nihon Shokakibyo Gakkai Zasshi; 1998 Aug; 95(8):900-4. PubMed ID: 9752701
[No Abstract] [Full Text] [Related]
53. In situ hybridization demonstration of albumin mRNA in B6C3F1 murine liver and hepatocellular neoplasms.
Pilling AM; Endersby-Wood HJ; Jones SA; Williams TC
Vet Pathol; 1997 Nov; 34(6):585-91. PubMed ID: 9396139
[TBL] [Abstract][Full Text] [Related]
54. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.
Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N
Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201
[TBL] [Abstract][Full Text] [Related]
55. Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
Sheen IS; Jeng KS; Shih SC; Wang PC; Chang WH; Wang HY; Shyung LR; Lin SC; Kao CR; Tsai YC; Wu TY
World J Gastroenterol; 2004 Jan; 10(1):31-6. PubMed ID: 14695764
[TBL] [Abstract][Full Text] [Related]
56. Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma.
Yu JJ; Xiao W; Dong SL; Liang HF; Zhang ZW; Zhang BX; Huang ZY; Chen YF; Zhang WG; Luo HP; Chen Q; Chen XP
BMC Cancer; 2018 Aug; 18(1):835. PubMed ID: 30126375
[TBL] [Abstract][Full Text] [Related]
57. Hepatocellular carcinoma diagnosis in bile duct brush cytology.
Stewart CJ; Stephen MR; Ferrier RK
Diagn Cytopathol; 1998 Aug; 19(2):149-50. PubMed ID: 9702497
[No Abstract] [Full Text] [Related]
58. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
59. [Imaging of pathological findings: hepatoma].
Honda H
Fukuoka Igaku Zasshi; 1998 Apr; 89(4):103-8. PubMed ID: 9597790
[No Abstract] [Full Text] [Related]
60. Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation.
Sánchez-Lorencio MI; Ramirez P; Saenz L; Martínez Sánchez MV; De La Orden V; Mediero-Valeros B; Veganzones-De-Castro S; Baroja-Mazo A; Revilla Nuin B; Gonzalez MR; Cascales-Campos PA; Noguera-Velasco JA; Minguela A; Díaz-Rubio E; Pons JA; Parrilla P
Transplant Proc; 2015 Nov; 47(9):2639-42. PubMed ID: 26680058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
